Аннотация:
Pathological lesions associated with multiple causes (infections, physical, chemical and thermal agents) of oral mucosa are equally widespread in all spheres of dental practice. The actual importance of pharmaceutical therapy of lesions of oral mucosa is associated with the lack of reliable traditional topical drugs - ointments, gels, pastes, lacquers, discs - caused by their little efficiency associated with poor maintaining of permanent concentration, short contact period, discomfort and long-term treatment. All the mentioned facts caused the development of various pharmaceutical forms with prolonged activity with improved adhesion to oral mucosa, prolonged saving of useful properties and protecting the lesion from oral infection and external influences and reducing the intensity of painful sensations during mastication and mimics. These drugs form the group of barrier drugs and drugs with prolonged release of medicine of the wide specter. During all the time of existence this group
Ключевые слова:
barrier drugs; dentistry; oral wounds healing; prolonged release of medicine
delayed release formulation; drug effect; gel; human; mouth disease; mouth mucosa; Delayed-Action Preparations; Gels; Humans; Mouth Diseases; Mouth Mucosa
Романова Ю. Ю. Юлиана Юрьевна 1990-
Макеева М. К.
Romanova Yu. Yu. Yuliana Yuryevna 1990-
Makeeva M. K.
Barrier drugs with prolonged release in dental practice [Bar'ernye sredstva s prolongirovannym vydeleniem medikamentoznykh preparatov v stomatologicheskoĭ praktike]
Barrier drugs with prolonged release in dental practice [Bar'ernye sredstva s prolongirovannym vydeleniem medikamentoznykh preparatov v...
Текст визуальный непосредственный
Стоматология
Издательство Медиа Сфера
Т. 97, Вып. 3 С. 65-68
2018
Статья
barrier drugs dentistry oral wounds healing prolonged release of medicine
delayed release formulation drug effect gel human mouth disease mouth mucosa Delayed-Action Preparations Gels Humans Mouth Diseases Mouth Mucosa
Pathological lesions associated with multiple causes (infections, physical, chemical and thermal agents) of oral mucosa are equally widespread in all spheres of dental practice. The actual importance of pharmaceutical therapy of lesions of oral mucosa is associated with the lack of reliable traditional topical drugs - ointments, gels, pastes, lacquers, discs - caused by their little efficiency associated with poor maintaining of permanent concentration, short contact period, discomfort and long-term treatment. All the mentioned facts caused the development of various pharmaceutical forms with prolonged activity with improved adhesion to oral mucosa, prolonged saving of useful properties and protecting the lesion from oral infection and external influences and reducing the intensity of painful sensations during mastication and mimics. These drugs form the group of barrier drugs and drugs with prolonged release of medicine of the wide specter. During all the time of existence this group